Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Guiu

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Clinical Nutrition (Edinburgh, Scotland)|January 3, 2012
Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetesJ M Petit, B Guiu, L Duvillard, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trialM Boulin, P Hillon, J P Cercueil, et al.
Revue Neurologique|June 21, 2008
[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study]S Guiu, S Taillibert, O Chinot, et al.
The British Journal of Surgery|March 4, 2021
Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysisJ Heil, R Korenblik, F Heid, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Clinical Nutrition (Edinburgh, Scotland)|January 3, 2012
Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetesJ M Petit, B Guiu, L Duvillard, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trialM Boulin, P Hillon, J P Cercueil, et al.
Revue Neurologique|June 21, 2008
[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study]S Guiu, S Taillibert, O Chinot, et al.
The British Journal of Surgery|March 4, 2021
Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysisJ Heil, R Korenblik, F Heid, et al.
Pageof 5